TNF and stricture: However, it is yet unclear whether the early use of anti‐TNFα could improve the natural history of CD, even though the annual surgical rates tend to decrease worldwide.14, 15, 16, 17 There is also controversy regarding whether anti‐TNFα therapy, particularly infliximab, would result in intestinal stricture progression.